Geneva, March 23 -- International Clinical Trials Registry received information related to the study (KCT0011691) titled 'A human trial to Lactiplantibacillus plantarum HY7714 on skin wrinkles, moisture, and pigmentation' on March 9.
Study Type: Interventional Study
Study Design:
Primary Purpose : Prevention, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Hy
Condition:
Not Applicable
Intervention:
Dietary Supplement : * Lactiplantibacillus plantarum HY7714 group: two capsules per day, orally after breakfast for 12 weeks (daily dose: 1 g/Lactiplantibacillus plantarum HY7714 dose: 1x10^10 CFU/day)
* Placebo group: two capsules per day, orally af...